$CTS

CTS Corporation (CTS) Stock Forecasts

Argus on Aug 12, 2026 lowered its target price for CTS Corp (CTS) to $72.00. The note describes CTS Corp as an electronics manufacturer of sensors, electronic components, and actuators. Other listed items include target or rating changes for APH, IPGP, ESE, AGYS, and LFUS.

Original reporting
Published Aug 13, 2026, 12:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CTS
Bearish
low confidence
Mentioned
$CTS
Relevance
4/10
alphai data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$CTSBearishLow
01

Why it matters

The only CTS-specific new fact is the Argus target price reduction to $72.00; no supporting thesis details are included in the provided text.

02

Market read

This is primarily a sentiment update from an analyst, not a fundamental disclosure.

03

What to watch

Traders should check whether other analysts issued concurrent revisions or whether CTS has upcoming earnings that could override PT changes.

Relevance 4/10Novelty 3/10Timing: analyst note dated Aug 12, 2026, reported pre-market Aug 13

Background

The article is a Yahoo Finance snippet summarizing an Argus analyst action for CTS and several other tickers.

Company-level read

Ticker impact

$CTSBearishLow confidence
Context

Argus lowered CTS Corp’s target price to $72.00 on Aug 12, 2026, signaling a bearish analyst view update.

Expected impact

Likely modest near-term downside bias versus peers, with follow-through depending on broader market/analyst revisions.

Evidence & confidence

The text only reports an analyst target change and does not include earnings, guidance, contract wins, or other fresh fundamentals.

Market effects

Limited signal for the broader electronics/sensors complex because the article contains only a single-company PT cut without sector-wide catalysts.

No regional macro or cross-market linkage provided.

No global supply chain, regulation, or demand shock mentioned.

Counterpoint

Target-price cuts can lag fundamentals; without new negative company-specific data, the market may discount the note quickly.

Key entities

  • CTS Corporation

    Electronics manufacturer of sensors, electronic components, and actuators; subject of the analyst target-price cut.

Related articles

$CTSMedAI 8/10

CTS Corporation Q2 2026 Earnings Call Summary

CTS Corporation reported Q2 2026 gross margin of 41.5% and said diversified end markets now make up 59% of revenue. Medical sales grew 45% YoY, industrial rose 16%, while transportation fell 2%. Full-year 2026 sales guidance was raised to $565-$585 million. Management expects aerospace strength in H2 and cautions on tariffs and precious metal inflation.

$CTSMedAI 8/10

Why CTS (CTS) Stock Is Up Today

CTS Corporation (NYSE: CTS) shares rose about 5.8% after the company reported Q2 results that beat expectations and raised full-year guidance. CTS said sales were $144.8 million (+7% YoY) and adjusted EPS was $0.74. It now expects 2026 revenue around $575 million (midpoint) and adjusted EPS of $2.63 (midpoint).

$CTSHigh

CTS CORP (CTS): Results of Operations and Financial Condition

CTS CORP (CTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cts-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 July 28, 2026 FOR IMMEDIATE RELEASE CTS Announces Second Quarter 2026 Results Strong diversification momentum drives record margins and profitability; 2026 outlook raised Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading gl

$CTSMed

ASX Runners of the Week: Ceretas, Pacgold & Hamelin Gold

The article links Middle East tensions to a jump in oil prices, with Brent up about 15% above US$100. It also cites Australia’s June employment gain of 76,300 and unemployment at 4.4%. ASX “runners” include Ceretas Ltd (CTS), up 142% after an $8m IPO for portable ultrasound in Alzheimer’s trials, and Pacgold Ltd (PGO), up 82% after high-grade copper-gold results at White Dam.